Document is current
Any future updates will be listed below
-
Authors
Ozdemir, Huseyin Baran https://orcid.org/0000-0002-5585-253X
Ozdal, Pinar Cakar https://orcid.org/0000-0002-5714-7172
- License Information
-
More Information
Article History
Received: 21 March 2021
Revised: 3 August 2021
Accepted: 22 August 2021
First Online: 27 September 2021
Declarations
:
: The study was approved by the Ethical Committee of Ankara Training and Research Hospital (No: 2020–191).
: Not applicable due to the retrospective nature of the study.
: Not applicable.
: Huseyin Baran Ozdemir has no conflicts of interest. Pinar Cakar Ozdal has received consultancy and lecture fees from AbbVie, Turkey; lecture fees from Novartis, Turkey; and lecture fees from Bayer, Turkey. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
